关于大麻消费对首发精神病前瞻性PAFIP队列中肝功能影响的数据。
Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis.
作者信息
Vázquez-Bourgon Javier, Ortiz-García de la Foz Víctor, Suarez-Pereira Irene, Iruzubieta Paula, Arias-Loste María Teresa, Setién-Suero Esther, Ayesa-Arriola Rosa, Gómez-Revuelta Marcos, Crespo Javier, Crespo Facorro Benedicto
机构信息
Department of Psychiatry, University Hospital de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain.
出版信息
Data Brief. 2019 Oct 25;27:104415. doi: 10.1016/j.dib.2019.104415. eCollection 2019 Dec.
The presented article describes data from secondary analyses, related to the research article entitled "Cannabis consumption and Non-Alcoholic Fatty Liver Disease. A three years longitudinal study in first episode non-affective psychosis patients" [1]. We present detailed data regarding the socio-demographic and baseline clinical characteristics of a sample of 390 drug-naïve patients with a first episode of non-affective psychosis, and the differences between cannabis users and non-users in those characteristics. Tables also show the results from cross-sectional and longitudinal statistical analyses exploring the relation between cannabis consumption and liver function, after excluding those patients with hazardous alcohol drinking.
本文介绍了二次分析的数据，这些数据与题为《大麻消费与非酒精性脂肪性肝病。首发非情感性精神病患者的三年纵向研究》的研究文章相关[1]。我们提供了390例首发非情感性精神病、未使用过药物患者样本的社会人口统计学和基线临床特征的详细数据，以及大麻使用者和非使用者在这些特征上的差异。表格还显示了在排除有危险饮酒行为的患者后，探索大麻消费与肝功能之间关系的横断面和纵向统计分析结果。
Zotero 插件